India  
NewsR.in
> >

J&J Ordered to Pay $4.69 Billion in Cancer Case

Video Credit: Wibbitz Studio - Duration: 01:17s - Published < > Embed
J&J Ordered to Pay $4.69 Billion in Cancer Case

J&J Ordered to Pay $4.69 Billion in Cancer Case

J&J Ordered to Pay $4.69 Billion in Cancer Case The St.

Louis city court jury ordered the company to pay after 22 women said the baby powder gave them ovarian cancer.

The case is linked to more than 9,000 similar claims. The women claimed the products contained asbestos which caused the cancer.

The plaintiff’s lawyer argued the company knew its products were contaminated and “rigged” tests.

J&J denied it and said they use the best labs for testing.

This is the sixth largest product-defect award in U.S. history.

Imerys SA was also sued since they provide the powder but settled the claim for $5 million.

Carol Goodrich, a J&J spokeswoman, said the verdict "was the product of a fundamentally unfair process.” The company plans to appeal the ruling.

">
0
shares
ShareTweetSavePostSend
 

You Might Like


Recent related videos from verified sources

Lilly to buy Loxo Oncology for $8 bln [Video]Lilly to buy Loxo Oncology for $8 bln

Eli Lilly will buy Loxo Oncology for about $8 billion in cash, making its biggest bet on a cancer therapy market expected to be worth several billions of dollars. Fred Katayama reports.

Credit: Reuters Studio     Duration: 01:12Published

Bristol-Myers Bulks Up Cancer Portfolio With $74 Billion Celgene Deal [Video]Bristol-Myers Bulks Up Cancer Portfolio With $74 Billion Celgene Deal

According to Reuters, Bristol-Myers Squibb said that it would buy Celgene for about $74 billion, creating a major pharma company with several blockbuster cancer drugs, as competition in the..

Credit: Wochit     Duration: 00:35Published

Bristol-Myers buys Celgene for $74 billion [Video]Bristol-Myers buys Celgene for $74 billion

Bristol-Myers Squibb is buying Celgene for about $74 billion, creating a major pharma company with several blockbuster cancer drugs as competition in the immunotherapy sector heats up. Fred Katayama..

Credit: Reuters Studio     Duration: 01:16Published

Judge Upholds $4 Billion Verdict Against Johnson & Johnson [Video]Judge Upholds $4 Billion Verdict Against Johnson & Johnson

A judge ruled against Johnson & Johnson's request to set aside a $4.69 billion verdict in a lawsuit over its talc products.

Credit: Newsy Studio     Duration: 00:50Published

Environmentally friendly: newsR is hosted on servers powered solely by renewable energy
© 2019 newsR Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Contact us  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest